Sin conexión a internet: se muestra la versión guardada de la página.

Sanofi ADR

FREUR
← Al Screener

Sanofi ADR (MI:1SAN) — Biotechnology: Pharmaceutical Preparations. Número de bolsas en las que cotizan las acciones de la empresa: 6. En esta página: cotización y gráfico, dividendos, principales accionistas e historial del número de acciones.

Sobre la Empresa

Sitio Web
sanofi.com
Relaciones con los Inversores
sanofi.com/en/investors
Sector
Health Care · Biotechnology: Pharmaceutical Preparations
Sede Central
PARIS, France
Gestión
Paul Hudson
Últimos Informes
trimestral 2026 · July 2026Half-year Financial ReportsHalf Year 202…
Empleados
106 566
Fundada
2004
Cotiza Desde
24.07.2006 (MI:1SAN)
Acciones en Circulación
1.22 mil M a 2025-12-31
Capital Flotante
2.16 mil M
Capitalización Bursátil
98.67 mil M USD
Insiders
0%
Inversores Institucionales
8.02%
Industria (SIC)
Pharmaceutical Preparations
Forma Jurídica
QVPB
ISIN
FR0000120578
LEI
549300E9PC51EN656011
P/E
22.8
P/B
1.27
Ratio de Reparto
≈64.0%
FCF
10.8 mil M EUR
Pagos / FCF
47%
Deuda
18.7 mil M EUR
1.0 a. de FCF
Racha de Dividendos
23 a.
Beneficios, FCF y dividendos pagados — para los 12 meses hasta 31.12.2025 (el último informe de la compañía).
NAV
58.53 EUR · P/NAV 1.27
Fecha del Balance31.12.2025
Activos127 mil M EUR
− Pasivos55.1 mil M EUR
= Patrimonio Total71.7 mil M EUR
− Participaciones No Dominantes334 M EUR
= NAV (patrimonio de los accionistas de la empresa)71.4 mil M EUR
− Fondo de Comercio41.3 mil M EUR
− Activos Intangibles26.3 mil M EUR
= NAV Tangible3.82 mil M EUR
Acciones1 219 427 096
NAV por Acción58.53 EUR
NAV Tangible por Acción3.13 EUR
Precio de la Acción (1SAN)74.2400 EUR
P/NAV1.27
Historial del NAV
Fecha del BalanceNAVNAV por Acción
31.12.202571.4 mil M EUR58.53 EUR
31.12.202477.5 mil M EUR61.36 EUR
31.12.202374.0 mil M EUR58.54 EUR
31.12.202274.8 mil M EUR59.31 EUR
31.12.202168.7 mil M EUR54.36 EUR
31.12.202063.1 mil M EUR50.46 EUR
31.12.201959.1 mil M EUR47.10 EUR
31.12.201858.9 mil M EUR47.27 EUR
Descripción

Sanofi engages in the research, development, manufacture, and marketing of therapeutic solutions. It provides immunology and inflammation, rare diseases neurology, oncology, and other vaccines. It also offers poliomyelitis, pertussis, and haemophilus influenzae type b (Hib) pediatric vaccines; respiratory syncytial virus protection; hexavalent combination vaccines that includes hepatitis A, typhoid, yellow fever, and rabies vaccines; and Fluzone, a flu vaccine. It has a collaboration and license agreement with Exscientia to develop up to 15 novel small-molecule for oncology and immunology; ABL Bio, Inc. to develop ABL301 for treatment of alpha-synucleinopathies; and Innate Pharma SA for cell engager program targeting B7-H3. Further, it has a collaboration agreements with Atomwise to use ATOMNET platform and Insilico Medicine to use Pharma.AI, a medicine's AI platform; Kymera Therapeutics, Inc. to develop and commercialize protein degrader therapies targeting IRAK4 in patients with immune-inflammatory diseases; Nurix Therapeutics, Inc. to develop protein degradation therapies; Denali Therapeutics Inc. to treat systemic inflammatory diseases, such as ulcerative colitis; and Adagene Inc. for development of antibody-based therapies. Additionally, it has a collaboration with Scribe Therapeutics Inc. to develop genome editing technologies; Teva Pharmaceuticals to co-develop and co-commercialize TEV'574, for treatment of ulcerative colitis and Crohn's disease; and co-promotion service agreement with Provention Bio, Inc. for the commercialization of teplizumab. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was incorporated in 1994 and is headquartered in Paris, France.

anuncio

Bolsas y Tickers

BolsaTickerMonedaPrecioTipo
PA Euronext ParisSAN principalEUR74.12 -1.11%acciones ordinarias
LSE London Stock Exchange0O59 IOBEUR71.63 +0.72%acciones ordinarias
MI Borsa Italiana (Milan)1SAN secundariaEUR74.24 -0.88%acciones ordinarias
US USA StocksSNYNF OTCUSD81.65 -0.80%acciones ordinarias
VI Vienna Stock ExchangeSANO secundariaEUR71.3 +1.03%acciones ordinarias
XETRA XetraSNW secundariaEUR71.78 -1.21%acciones ordinarias

Precio en 3 Meses

día alcista día bajista fecha ex-dividendo fecha de pagoPasa el cursor / toca un día — precios de apertura, cierre, máximo y mínimo

Dividendos

Por año, MI:1SAN: 4.12 EUR (1 pagos)

Sanofi ADR (1SAN) paga dividendos una vez al año. Por año (12 meses hasta e incluyendo el último pago anunciado): 4.12 EUR por acción (pagos: 1). Eso representa aproximadamente el 5.55% del precio actual de la acción. Según el historial de pagos, se espera la próxima fecha ex-dividendo alrededor de 04.05.2027. Historial de dividendos ininterrumpido: 23 años.

Fecha ExPagoImporte%TipoTicker
2026-05-052026-05-074.1200 EUR5.3/5.3 %anualMI:1SAN
2025-05-122025-05-143.9200 EUR4.2/4.2 %anualMI:1SAN
2024-05-132024-05-153.7600 EUR4.0/4.0 %anualMI:1SAN
2023-05-30—3.5600 EUR3.6/3.6 %anualMI:1SAN
2022-05-06—3.3300 EUR3.3/3.3 %anualMI:1SAN

Principales Accionistas

TitularParticipaciónAccionesFecha del Informe
Dodge & Cox Inc.10.54%28.09 M2026-06-30
Dodge & Cox Funds-Dodge…7.84%20.9 M2026-06-30
Morgan Stanley4.02%10.7 M2026-06-30
Fisher Asset Management,…3.99%10.63 M2026-06-30
Bank of America Corporat…3%8.01 M2026-06-30
Invesco Ltd.2.55%6.8 M2026-06-30
JPMORGAN CHASE & CO2.47%6.57 M2026-06-30
Mondrian Investment Part…2.07%5.52 M2026-06-30
Brandes Investment Partn…1.55%4.14 M2026-06-30
AIM Sector Funds (Invesc…1.51%4.03 M2026-04-30
Federated Hermes, Inc.1.44%3.85 M2026-06-30
Boston Partners1.44%3.84 M2026-06-30
VANGUARD STAR FUNDS-Vang…1.31%15.85 M2026-07-31
Putnam ETF Trust-Putnam…1.26%3.36 M2026-05-31
VANGUARD TAX-MANAGED FUN…0.87%10.53 M2026-06-30
iShares Trust-iShares Co…0.67%8.11 M2026-08-31
Dodge & Cox Funds-Dodge…0.63%1.67 M2026-06-30
AMERICAN MUTUAL FUND0.59%1.58 M2026-06-30
American Century Capital…0.37%976 5612026-06-30
Bridge Builder Trust-Bri…0.36%967 1002026-06-30
Fidelity Concord Street…0.35%4.24 M2026-07-31
VanEck ETF Trust-VanEck…0.35%938 5612026-08-31
Dodge & Cox Funds-Dodge…0.33%4.04 M2026-06-30
iShares Trust-iShares MS…0.32%3.89 M2026-08-31
Capital World Growth & I…0.3%3.67 M2026-06-30
-Victory Pioneer Core Eq…0.3%799 4872026-06-30
Fidelity Covington Trust…0.3%797 1842026-08-31
NEW PERSPECTIVE FUND0.29%3.56 M2026-06-30
Federated Hermes Eqy. Fd…0.29%3.48 M2026-07-31
Bridge Builder Trust-Bri…0.29%3.44 M2026-06-30
Pacer Advisors, Inc.0.1%1.16 M2026-06-30
Generali Investments Cee…0%29 3392026-06-30
Paradigm Asset Managemen…0%19 2002026-06-30
Gamma Investing LLC0%582026-06-30
L'Oréal———